Genetic and behavioral modification of hemoglobin and iron status among first‐time and high‐intensity blood donors
- 12 March 2020
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 60 (4), 747-758
- https://doi.org/10.1111/trf.15743
Abstract
BACKGROUND Some people rapidly develop iron deficiency anemia following blood donation, while others can repeatedly donate without becoming anemic. METHODS Two cohorts of blood donors were studied. Participants (775) selected from a 2‐year longitudinal study were classified into six analysis groups based on sex, donation intensity, and low hemoglobin deferral. Associations with iron supplement use, cigarette smoking, and four genetic variants of iron metabolism were examined at enrollment and with longitudinal regression models. An unbiased assessment of genetic variability and ability to repeatedly donate blood without experiencing low hemoglobin deferral was conducted on participants (13,403) in a cross‐sectional study who were examined by genome wide association (GWA). RESULTS Behaviors and genetic variants were associated with differences in hemoglobin and ferritin change following repeated donation. At least weekly iron supplement use was associated with improved status in first‐time donors, while daily use was associated with improved status in high‐intensity donors. Cigarette smoking was associated with 0.5 g/dL increased hemoglobin in high‐intensity donors. A736V in TMPRSS6 was associated with a rapid drop in hemoglobin and ferritin in first‐time females following repeated donation. Conversely, the protective TMPRSS6 genotype was not enriched among high‐intensity donors. H63D in HFE was associated with increased hemoglobin in female high‐intensity donors. However, no differences in genotype between first‐time and high‐intensity donors were found in GWA analyses. CONCLUSION Behavioral and genetic modifiers contributed to first‐time donor hemoglobin and iron status, while iron supplement use was more important than underlying genetics in high‐intensity donors.Funding Information
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- University of British Columbia
- American Red Cross
- Blood Systems Research Institute
- American Red Cross
- Tufts University School of Medicine
- Yale University
- U.S. Department of Veterans Affairs
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (00009I, 00008I, 00007I, 00006I, 00005I, 00004I, 00003I, 00002I, HHSN2682011‐00001I)
This publication has 40 references indexed in Scilit:
- Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomyHaematologica, 2013
- Population‐based screening for anemia using first‐time blood donorsAmerican Journal of Hematology, 2012
- The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*British Journal of Haematology, 2011
- Iron deficiency in blood donors: the REDS‐II Donor Iron Status Evaluation (RISE) studyTransfusion, 2011
- Iron deficiency in blood donors: analysis of enrollment data from the REDS‐II Donor Iron Status Evaluation (RISE) studyTransfusion, 2010
- Demographic correlates of low hemoglobin deferral among prospective whole blood donorsTransfusion, 2010
- Multiple loci influence erythrocyte phenotypes in the CHARGE ConsortiumNature Genetics, 2009
- Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levelsNature Genetics, 2009
- Common variants in TMPRSS6 are associated with iron status and erythrocyte volumeNature Genetics, 2009
- The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane HemojuvelinCell Metabolism, 2008